DAPIROLIZUMAB PEGOL EFFICACY BY SUBGROUPS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A POST HOC ANALYSIS OF PHASE 2 CLINICAL TRIAL DATA

Askanase, A; Stach, C; Brittain, C; Stojan, G; Furie, R

ANNALS OF THE RHEUMATIC DISEASES, 2023; 82 (): 272